Irene Cantarero Carmona-rekin lankidetzan egindako argitalpenak (4)

2018

  1. VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways

    British Journal of Pharmacology, Vol. 175, Núm. 19, pp. 3813-3831

2016

  1. The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

    Scientific Reports, Vol. 6

  2. VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease

    Scientific Reports, Vol. 6

2012

  1. A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis

    Journal of Neuroimmune Pharmacology, Vol. 7, Núm. 4, pp. 1002-1016